In this article, we are going to take a look at where Structure Therapeutics Inc. (NASDAQ:GPCR) stands against the other weight loss stocks. Most people have at some point sought to include weight ...

Exicure revealed it has agreed to purchase all shares of GPCR Therapeutics USA, the California-based subsidiary of GPCR Therapeutics. As part of the agreement, Exicure and GPCR have entered into a ...

Spire Wealth Management bought a new stake in Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 8,949 shares of the company’s ...

EXICURE, INC. ANNOUNCES PURCHASE AGREEMENT WITH GPCR THERAPEUTICS INC. Exicure, Inc. (Nasdaq: XCUR, "the Company", "Exicure"), today announced that on January 19 ...

Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have been assigned an average rating of “Buy” from the ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...

Heptares was founded in 2007 on this technology, and Nxera is building on this long history and experience to develop the next generation of GPCR-targeted drugs — and beyond. With more than 800 ...

Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing ...